Encyclopedia

  • Novel phosphoramidates with porphine and nitrogenous drug: One-pot synthesis and orientation to cancer cells
  • Add time:07/14/2019         Source:sciencedirect.com

    One-pot synthesis of novel phosphoramidates with porphine and nitrogenous drug was accomplished. In the absence of light, MTT test showed that they killed the BEL-7402 liver cancer cells effectively in vitro. The cell viability studied on normal liver and cancer cells showed that porphine phosphoramidates selectively kill the cancer cells, which was in sharp contrast with the non-porphine containing compound 4-formylphenyl N,N-bis(2-chloroethyl)-phosphoramidate. These results, coupled with the cell uptake test showing that they could differentiate the tumor cells from the normal cells by their selective accumulation in cancer cells, gave strong support to the notion that the introduction of porphine moiety in these molecules was responsible for the effectiveness and cell differentiability of these porphine phosphoramidates.

    We also recommend Trading Suppliers and Manufacturers of diethyl (4-methylphenyl)phosphoramidate (cas 20809-97-6). Pls Click Website Link as below: cas 20809-97-6 suppliers


    Prev:Trypanosoma cruzi trans-sialidase alternative substrates: Study of the effect of substitution in C-6 in benzyl β-lactoside
    Next: Structural diversity in phosphoramidate’s chemistry: Syntheses, spectroscopic and X-ray crystallography studies)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View